Clinical Trial Update: Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002) [Phase 3]

View source ↗

Summary

Phase 3 trial update for preservative-free tafluprost (MK-2452) in open-angle glaucoma or ocular hypertension completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Tafluprost (tafluprost)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2014-05-09